Results for tag: "Ragwitek"

Ragwitek is a sublingual immunotherapy (SLIT) drug used to treat allergies. It is a tablet that is placed under the tongue and dissolves, releasing a small amount of allergen extract. The Ragwitek market is composed of pharmaceutical companies that manufacture and distribute the drug. The drug is approved for use in adults and children over the age of five who suffer from grass pollen-induced allergic rhinitis. It is the first and only SLIT tablet approved by the US Food and Drug Administration (FDA). The Ragwitek market is a rapidly growing sector of the allergy drug market. It is expected to continue to grow as more people become aware of the benefits of SLIT therapy. Companies in the Ragwitek market include Merck, ALK-Abello, Stallergenes Greer, and Allergy Therapeutics. These companies are involved in the research, development, manufacturing, and distribution of Ragwitek. Show Less Read more